Giugliano RP - Search Results

1

Adenosine Triphosphate Citrate Lyase and Fatty Acid Synthesis Inhibition: A Narrative Review.

Duarte Lau F, Giugliano RP. Duarte Lau F, et al. Among authors: giugliano rp. JAMA Cardiol. 2023 Sep 1;8(9):879-887. doi: 10.1001/jamacardio.2023.2402. JAMA Cardiol. 2023. PMID: 37585218 Review.

2

Updates on Acute Coronary Syndrome: A Review.

Eisen A, Giugliano RP, Braunwald E. Eisen A, et al. Among authors: giugliano rp. JAMA Cardiol. 2016 Sep 1;1(6):718-30. doi: 10.1001/jamacardio.2016.2049. JAMA Cardiol. 2016. PMID: 27438381 Review.

3

Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis.

Silverman MG, Ference BA, Im K, Wiviott SD, Giugliano RP, Grundy SM, Braunwald E, Sabatine MS. Silverman MG, et al. Among authors: giugliano rp. JAMA. 2016 Sep 27;316(12):1289-97. doi: 10.1001/jama.2016.13985. JAMA. 2016. PMID: 27673306 Review.

4

Cardiovascular Biomarker Score and Clinical Outcomes in Patients With Atrial Fibrillation: A Subanalysis of the ENGAGE AF-TIMI 48 Randomized Clinical Trial.

Ruff CT, Giugliano RP, Braunwald E, Murphy SA, Brown K, Jarolim P, Mercuri M, Antman EM, Morrow DA. Ruff CT, et al. Among authors: giugliano rp. JAMA Cardiol. 2016 Dec 1;1(9):999-1006. doi: 10.1001/jamacardio.2016.3311. JAMA Cardiol. 2016. PMID: 27706467

5

Association Between Circulating Baseline Proprotein Convertase Subtilisin Kexin Type 9 Levels and Efficacy of Evolocumab.

Desai NR, Giugliano RP, Wasserman SM, Gibbs JP, Liu T, Scott R, Sabatine MS. Desai NR, et al. Among authors: giugliano rp. JAMA Cardiol. 2017 May 1;2(5):556-560. doi: 10.1001/jamacardio.2016.5395. JAMA Cardiol. 2017. PMID: 28122070 Free PMC article.

6

Atrial Fibrillation, Type 2 Diabetes, and Non-Vitamin K Antagonist Oral Anticoagulants: A Review.

Plitt A, McGuire DK, Giugliano RP. Plitt A, et al. Among authors: giugliano rp. JAMA Cardiol. 2017 Apr 1;2(4):442-448. doi: 10.1001/jamacardio.2016.5224. JAMA Cardiol. 2017. PMID: 28122078 Review.

7

Long-term Safety and Efficacy of Achieving Very Low Levels of Low-Density Lipoprotein Cholesterol : A Prespecified Analysis of the IMPROVE-IT Trial.

Giugliano RP, Wiviott SD, Blazing MA, De Ferrari GM, Park JG, Murphy SA, White JA, Tershakovec AM, Cannon CP, Braunwald E. Giugliano RP, et al. JAMA Cardiol. 2017 May 1;2(5):547-555. doi: 10.1001/jamacardio.2017.0083. JAMA Cardiol. 2017. PMID: 28291866 Free PMC article. Clinical Trial.

8

Long-term Low-Density Lipoprotein Cholesterol-Lowering Efficacy, Persistence, and Safety of Evolocumab in Treatment of Hypercholesterolemia: Results Up to 4 Years From the Open-Label OSLER-1 Extension Study.

Koren MJ, Sabatine MS, Giugliano RP, Langslet G, Wiviott SD, Kassahun H, Ruzza A, Ma Y, Somaratne R, Raal FJ. Koren MJ, et al. Among authors: giugliano rp. JAMA Cardiol. 2017 Jun 1;2(6):598-607. doi: 10.1001/jamacardio.2017.0747. JAMA Cardiol. 2017. PMID: 28291870 Free PMC article.

9

Major Bleeding in Patients With Diabetes and Atrial Fibrillation Treated With New Oral Anticoagulants-Reply.

Plitt A, McGuire DK, Giugliano RP. Plitt A, et al. Among authors: giugliano rp. JAMA Cardiol. 2017 Oct 1;2(10):1168. doi: 10.1001/jamacardio.2017.2034. JAMA Cardiol. 2017. PMID: 28658488 No abstract available.

10

Cost-effectiveness of Evolocumab Therapy for Reducing Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease.

Fonarow GC, Keech AC, Pedersen TR, Giugliano RP, Sever PS, Lindgren P, van Hout B, Villa G, Qian Y, Somaratne R, Sabatine MS. Fonarow GC, et al. Among authors: giugliano rp. JAMA Cardiol. 2017 Oct 1;2(10):1069-1078. doi: 10.1001/jamacardio.2017.2762. JAMA Cardiol. 2017. PMID: 28832867 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

482 results

Search Page